TET2 loss promotes premalignant survival and clonal selection in MYC-driven B cell lymphoma
Sarah Spoeck, Nadine Kinz, Irene Rigato, Katharina Hoppe, Julia Heppke, Paul Y. Petermann, Johannes G. Weiss, Miriam Erlacher, Michaël Schubert, Joel S. Riley, Andreas Villunger, Francesca Finotello, Verena Labi
This study shows that TET2 loss increases lymphoma penetrance and promotes survival of premalignant B cells in MYC-driven lymphoma by reducing apoptosis.
bioRxiv · Mar 21, 2026 · PreprintCancer Biology